Dimensional Fund Advisors LP Milestone Pharmaceuticals Inc. Transaction History
Dimensional Fund Advisors LP
- $363 Billion
- Q1 2024
A detailed history of Dimensional Fund Advisors LP transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 39,450 shares of MIST stock, worth $59,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,450
Previous 73,704
46.48%
Holding current value
$59,175
Previous $123,000
43.09%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MIST
# of Institutions
47Shares Held
31.3MCall Options Held
3.3KPut Options Held
3.5K-
Black Rock Inc. New York, NY4.97MShares$7.46 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.26MShares$4.88 Million0.09% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.86MShares$4.28 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.37MShares$3.56 Million2.21% of portfolio
-
Lion Point Capital, LP New York, NY2.3MShares$3.45 Million2.63% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $45M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...